Next Article in Journal
Secondary Metabolites, Biological Activities, and Industrial and Biotechnological Importance of Aspergillus sydowii
Next Article in Special Issue
Anti-Atopic Dermatitis Activity of Epi-Oxyzoanthamine Isolated from Zoanthid
Previous Article in Journal
Microalgae: A Promising Source of Bioactive Phycobiliproteins
Previous Article in Special Issue
Anti-Diabetic Activity of a Novel Exopolysaccharide Produced by the Mangrove Endophytic Fungus Penicillium janthinellum N29
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

New Sorbicillinoids from the Mangrove Endophytic Fungus Trichoderma reesei SCNU-F0042

1
GDMPA Key Laboratory for Process Control and Quality Evaluation of Chiral Pharmaceuticals, School of Chemistry, South China Normal University, Guangzhou 510006, China
2
Key Laboratory of Tropical Disease Control, Ministry of Education, Department of Biochemistry, Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou 510080, China
*
Author to whom correspondence should be addressed.
Mar. Drugs 2023, 21(8), 442; https://doi.org/10.3390/md21080442
Submission received: 15 July 2023 / Revised: 3 August 2023 / Accepted: 3 August 2023 / Published: 5 August 2023
(This article belongs to the Special Issue Pharmacological Potential of Marine Natural Products)

Abstract

:
Three new dimeric sorbicillinoids (13) and one new 3,4,6-trisubstituted α-pyrone (5), along with seven analogues (4 and 611), were isolated from the mangrove endophytic fungus Trichoderma reesei SCNU-F0042 under the guidance of molecular networking approach. Their chemical structures were established by 1D and 2D NMR HR-ESI-MS and ECD analysis. In a bioassay, compound 2 exhibited moderate SARS-CoV-2 inhibitory activity with an EC50 value of 29.0 μM.

Graphical Abstract

1. Introduction

Trichoderma sp. is a widespread filamentous fungus of ascomycetes in various types of soils [1]. Among them, the mangrove-derived fungal genus Trichoderma produces a diverse array of secondary metabolites including alkaloids, polyketides, terpenoids, phenols, lactones, and various hybrids of the aforementioned classes [2,3,4,5,6]. Sorbicillinoids, a marker secondary metabolite of Trichoderma reesei (T. reesei), have a characteristic sorbyl side chain and a cyclic hexaketide nucleus in the structures [7,8]. Since sorbicillin was first discovered from Penicillium notatum in 1948, more than 100 analogs of sorbicillinoids have been reported and they can be classified into monomeric-, bi-, tri-, and hybrid sorbicillinoids by the number of sorbicillinoid construction units [9,10]. Many of them exhibited a wide range of biological activities, such as cytotoxic [11], antibacterial [12], antifungal [13], anti-inflammatory [14], phytotoxic [15], and α-glucosidase inhibitory activity [16].
Molecular networking, a strategy that organizes and analyses MS/MS data based on chemical similarity, can be used for dereplication in natural products discovery [17]. After extraction and concentration, the EtOAc extract was subjected to LC-MS/MS analysis, then the data were uploaded to the Global Natural Product Social Molecular Networking (GNPS; www.gnps.ucsd.edu) platform, followed by MN analysis using the online workflow. A comprehensive examination of the MS2 spectra libraries allowed the annotation of the node at m/z 497.217 (C28H33O8, [M + H]+) as the bislongiquinolide (4) based on its fragmentation pattern [18]. By the guidance of bislongiquinolide node, more new bioactive sorbicillinoids remain to be discovered in the metabolites from the fungus Trichoderma reesei SCNU-F0042 (Figure 1 and Figure S28). Eventually, under the guidance of molecular networking, three new dimeric sorbicillinoids (13) and one new 3,4,6-trisubstituted α-pyrone (5), as well as seven analogues (4 and 611) were isolated from the mangrove-derived fungus Trichoderma reesei SCNU-F0042 (Figure 2). Details of the isolation, structure elucidation, and bioactivities of these compounds are reported herein.

2. Results

14-hydroxybislongiquinolide (1) was yellowish amorphous powder. Its molecular formula was determined as C28H32O9 by 13C NMR and negative-ion HRESIMS data (m/z 511.1975, [M-H], calcd for C28H31O9, 511.1974), indicating 13 indices of hydrogen deficiency. The 1H NMR data (Table 1, Figure S1) of 1 showed resonances of five methyls [δH 1.89 (3H, d, J = 6.1 Hz), 1.45(3H, s), 1.38(3H, s), 1.18(3H, s), and 0.99(3H, s)], one oxygenated methylene [δH 4.22(2H, d, J = 4.4 Hz), three methines [δH 3.36(H, d, J = 5.6 Hz), 3.34(H, s), and 3.22(H, d, J = 5.6 Hz)], and eight olefinic protons [δH 7.35(H, dd, J = 14.5, 11.2 Hz), 7.20(H, dd, J = 15.3, 10.7 Hz), 6.55–6.59(H, m), 6.43–6.49(H, m), 6.38–6.42(H, m), 6.31–6.35(H, m), 6.25–6.29(H, m), and 6.18(H, d, J = 15.3 Hz)]. The 13C NMR data (Table 1, Figure S2) revealed 28 carbon resonances corresponding to four carbonyls (δC 210.3, 203.1, 198.3, and 179.1), five methyls (δC 24.1, 23.3, 19.1, 11.4, and 6.4), one oxygenated methylene (δC 63.0), three methines (δC 52.2, 43.9, and 43.6), twelve olefinic C-atoms (δC 185.5, 168.6, 147.9, 144.9, 143.0, 142.5, 131.7, 129.9, 128.8, 121.6, 111.7, and 94.7), and three quaternary (δC 84.8, 75.9, and 63.7). These NMR data were similar to those of bislongiquinolide (4), which was previously isolated from the fungi Trichoderma longibrachiatum Rifai aggr., indicating that they had the same core skeleton structure [18]. The major difference was the replacement of the C-14 methyl group of the alkene in the side chain in bislongiquinolide by an hydroxymethyl (δC/H 63.0/4.22) in 1, which was further supported by the key 1H−1H COSY correlations (Figure 3 and Figure S3) of H-10/H-11/H-12/H-13/H2-14 and HMBC correlations (Figure S5) from H2-14(δH 4.22) to C-12(δC 129.9), C-13(δC 143.0) and from H-16(δH 6.18), H-17(δH 7.20) to C-15(δC 203.1). To determine relative and absolute configurations of compound 1, the method of nuclear overhauser effect spectroscopy (NOESY) correlations (Figure 4), coupling constants (Table 1), circular dichroism (CD) spectra (Figure 5), and biogenetic considerations were used. The E geometries of double bonds about Δ10, Δ12, Δ16, and Δ18 were deduced based on the coupling constants of H-11 (J = 14.5, 11.2 Hz) and H-17 (J = 15.3, 10.7 Hz). In addition, the NOE correlations (Figure 4 and Figure S6) of 5-CH3(δH 1.18)/H-10(δH 6.43–6.49) and H-4(δH 3.34)/H-10(δH 6.43–6.49) suggest Δ3 was the Z-type and 5-CH3 and H-4 were located on the side chain from C-9 through C-14. The NOESY correlations of H-10(δH 6.43–6.49)/21-CH3 (δH 1.38) and H-4(δH 3.34)/21-CH3 (δH 1.38) were oriented H-4 and 21-CH3 to the side chain from C-9 to C-14, which is the same as 5-CH3. The NOESY correlations of 1-CH3 (δH 0.99)/H-17 (δH 7.20) and H-17(δH 7.20)/23-CH3 (δH 1.45) indicated that the same orientation of 1-CH3 and 23-CH3 with another side chain from C-7 through C-20. The 7R*, 8S* relative configuration was suggested by the coupling constant (J7,8 = 5.6 Hz) [18]. Thus, the relative configuration of compound 1 should be 1R*, 4S*, 5S*, 7R*, 8S*, 21S*, which adopted the same configuration of the bicyclo [2.2.2] octanedione core as bislongiquinolide (4) [18]. The absolute configurations of compound 1 proposed to the absolute configurations were 1R, 4S, 5S, 7R, 8S, 21S, which were the same as bislongiquinolide (4) comparisons of the information between them, including the similar optical rotation values, the biosynthetic pathway, the trend in CD curves (Figure 5), and the chemical shifts [19]. Hence, compound 1 was identified as the 14-hydroxylated analogue of bislongiquinolide (4), and named as 14-hydroxybislongiquinolide.
20-hydroxybislongiquinolide (2) was isolated as a yellowish amorphous powder. The molecular formula of 2, the same as 1, was determined as C28H32O9 by HRESIMS in observing a protonated molecular ion at m/z 511.1975 [M-H] (calcd for C28H31O9, 511.1974). In addition, the hydrogen protons and carbons of 1 and 2 were also of the same type by comparison of the NMR data. However, the position of the hydroxymethyl group was changed from C-14 to C-20, which was confirmed by the key 1H−1H COSY correlations (Figure 3 and Figure S10) of H-16/H-17/H-19/H-19/H2-20, as well as HMBC correlations (Figure S12) from H2-20(δH 4.22) to C-18(δC 128.5), C-19(δC 147.6) and from H-17(δH 7.25), H-16(δH 6.32) to C-15(δC 202.5). The relative configuration of 2 was the same as 1 based on their similar NOESY correlations (Figure 4). Together, they shared the same ECD Cotton effect at 226, 280 and 320 nm of 2 in the experimental ECD spectrum, which was identical to that of 1 (Figure 5). Thus, the absolute configuration of 2 was identified as 1R, 4S, 5S, 7R, 8S, 21S. The structure of 2 was established and named as 20-hydroxybislongiquinolide.
14, 20-dihydroxybislongiquinolide (3) was obtained as a yellowish amorphous powder and it was analyzed by HRESIMS (m/z 527.1925 [M−H], calcd. 527.1923) for the molecular formula C28H32O10, which had an extra oxygen atom than 1. Its 1H and 13C NMR data (Table 1, Figures S15 and S16) were very similar to those of 1, with the exception that the methyl signals (C-20, δC/H 19.1/1.89) in 1 were replaced by hydroxymethyl signals (C-20, δC/H 63.0/4.22). This deduction was also confirmed by the key 1H−1H COSY correlations (Figure 3 and Figure S17) of H-10/H-11/H-12/H-13/H2-14 and H-16/H-17/H-18/H-19/H2-20. The relative configuration of 3 was also the same as 1 deduced from the NOESY correlations (Figure 4). At the same time, the experimental ECD of 3 also has a negative Cotton effect at 226 and 320 nm, as well as positive Cotton effect at 280 nm, just like that of 1 (Figure 5). Therefore, the absolute configuration of 3 was identified as 1R, 4S, 5S, 7R, 8S, 21S and 3 was determined as 14, 20-dihydroxybislongiquinolide.
Acetylchrysopyrone B (5), a yellowish amorphous powder, has a molecular formula of C13H12O6 determined by HREIMS data (m/z 263.0560 [M-H]; calcd for C13H11O6, 263.0561), with 8 degrees of unsaturation. The 1H NMR spectral data (Table 2, Figure S22), along with the HSQC data, informed the presence of two methyls [δH 2.34(3H, s) and 1.91(3H, s)] and five olefinic protons [δH 7.37(1H, dd, J = 15.2, 11.5 Hz), 7.15(1H, dd, J = 15.2, 11.5 Hz), 6.70 (1H, d, J = 15.2 Hz), 6.28 (1H, d, J = 15.2 Hz), and 6.47(1H, s)]. The 13C NMR and HSQC spectra (Figures S23 and S25) displayed 13 carbon resonances, including two carbonyls (δC 167.9 and 163.6), one carboxyl (δC 167.4), eight olefinic C-atoms (δC 158.9, 155.6, 143.4, 132.2, 130.2, 126.6, 115.5, and 106.6) and two methyls (δC 20.8 and 10.3). The above spectroscopic features suggested that 5 had a close structural relationship to chrysopyrone B [20], and the only difference was the appearance of the acetyl group connected to 4−OH, which was confirmed by the HMBC correlations from H3-8 to C-4 and C-7, and from H3-3 to C-4 and C-7 (Figure 3 and Figure S26). The geometry of double bonds Δ1′ and Δ3′ were deduced based on the coupling constants of H-2′ and H-3′ (J = 15.2, 11.5 Hz), suggesting the E-type of D1′ and D3′ double bonds. Therefore, the structure of 5 was proposed and named acetylchrysopyrone B.
The structures of the known compounds, bislongiquinolide (4) [18], saturnispol H (6) [21], sorbicillin (7) [22], trichodimerol (8) [23], bisorbicillinolide (9) [24], saturnispol B (10) [21], and bisvertinolone (11) [25], were recognized by comparing with their spectroscopic data reported in the literature. In terms of biological activity, the known compounds 4 and 611 have been evaluated for antibacterial [18,21,26], anti-inflammatory [14], radical scavenging activity [24], and PPARγ agonist [27], etc.
Biological activities of all new compounds were evaluated in virus bioassays. The results showed that compound 2 displayed moderate antiviral activity against SARS-CoV-2, the causative agent of COVID-19 infection, as assessed in 293T cells, exhibiting an EC50 value of 29.0 μM, while compounds 1, 3, and 5 displayed no activity at 80 μM. All the tested compounds showed no cytotoxicity at 80 μM. Remdesivir (IC50 = 1.2 μM) was used as a positive control (Table 3).

3. Experimental Section

3.1. General Experimental Procedures

Optical rotations were recorded on an Anton Paar (MCP 500) polarimeter at 25 °C (Graz, Austria), and ECD spectra were acquired on an Applied Photophysics Chirascan spectropolarimeter (Surrey, UK). HRESIMS spectra were obtained on a ThermoFisher LTQ−Orbitrap−LCMS spectrometer (Palo Alto, CA, USA). A Bruker AVANCE NEO 600 MHz spectrometer (Bruker BioSpin, Rheinstetten, Germany) was used to record the 1D and 2D NMR using TMS as an internal reference at room temperature. Column chromatography (CC) was performed on silica gel (100–200 and 200–300 mesh; Qingdao Marine Chemical Factory, Qingdao, China) and Sephadex LH-20 (25–100 μm; GE Healthcare Bio-Sciences AB, Stockholm, Sweden). HPLC analysis uses a Waters 2695 system (Waters, Milford, MA, USA) with an ACE Excel 5 C18-AR column (250 × 4.6 mm, 5 μm; Hichrom Limited, Leicestershire, UK).

3.2. Fungal Material

The fungal strain Trichoderma reesei SCNU-F0042 was isolated from the fresh bark of the mangrove plant Bruguiera gymnorhiza collected from Qi’ao Island Mangrove Nature Reserve, Zhuhai City, Guangdong Province, China. The fungus was obtained using the standard protocol for isolation. The sequence data of the fungal strain have been deposited at Gen Bank with accession no. OP978317. A BLAST search result showed that the sequence was the most similar (99%) to the sequence of Trichoderma reesei (compared to OK445677.1). A voucher strain was deposited in School of Chemistry, South China Normal University, Guangzhou, China, with the access code Trichoderma reesei SCNU-F0042.

3.3. General Experimental Procedures

Spores of the fungal strain were inoculated into solid autoclaved rice medium in 400 1L Erlenmeyer flasks, each of which contained 50 g rice and 50 mL 0.3% sea salt, culturing in room temperature under static condition for 30 days. The mycelia and solid rice medium were soaked with MeOH and extracted with EtOAc three times. The organic solvents were evaporated under 48 °C with reduced pressure and obtained 158.6 g of organic crude extract. The extract was isolated by column chromatography over silica gel eluting with a gradient of PE/EA (1:0−0:1) to yield 5 fractions (Frs. 1−5). Fr. 3 (2.87 g) was subjected to Sephadex LH−20 (DCM/MeOH v/v, 1:1) to afford four sub-fractions (SFrs. 3.1−3.4). SFr. 3.2 (674.2 mg) was applied to silica gel CC (DCM/MeOH v/v, 60:1.5) to give compound 4(28.1 mg) and compound 5 (8.2 mg). Fr. 4 (3.62 g) was subjected to Sephadex LH−20 (DCM/MeOH v/v, 1:1) to afford four sub-fractions (SFrs. 4.1−4.3). SFr. 4.2 (641.3 mg) was applied to silica gel CC (DCM/MeOH v/v, 60:2) to give compound 7 (5.1mg), compound 9 (4.4 mg) and compound 11 (7.6 mg). Fr. 5 (1.82 g) was subjected to Sephadex LH−20 (DCM/MeOH v/v, 1:1) to afford three sub-fractions (SFrs. 5.1−5.3). SFr. 5.2 (582.1 mg) was applied to silica gel CC (DCM/MeOH v/v, 60:4) to afford two sub-fractions (SFrs. 5.2.1 and SFrs. 5.2.4). SFrs. 5.2.1 (85.3 mg) was further purified by Sephadex LH-20 CC eluted with MeOH to give compound 1 (8.2 mg). SFrs. 5.2.2 (68.1 mg) was further purified by silica gel CC (DCM/MeOH v/v, 60:3) to give compound 2 (4.3 mg). SFrs. 5.2.3 (56.5 mg) was further purified by silica gel CC (DCM/MeOH v/v, 60:3.5) to give compound 6 (4.6 mg) and compound 8 (4.2 mg). Fr. 6 (1.43 g) was subjected to Sephadex LH−20 (DCM/MeOH v/v, 1:1) to afford four sub-fractions (SFrs. 6.1−6.4). SFr. 6.2 (321.7 mg) was applied to silica gel CC (DCM/MeOH v/v, 60:4.5) to afford three sub-fractions (SFrs. 6.2.1—SFrs. 6.2.3). SFrs. 6.2.2 (32.5 mg) was further purified by Sephadex LH-20 CC eluted with MeOH to give compound 3 (3.1 mg). SFrs. 6.2.3 (46.0 mg) was further purified by silica gel CC (DCM/MeOH v/v, 60:4) eluted with MeOH to give compound 10 (6.1 mg)

3.4. Spectral and Physical Data of Compounds 13 and 5

14-hydroxybislongiquinolide (1): Yellowish amorphous powder; [α]25D + 143 (c = 0.1, MeOH); UV (MeOH) λmax (log ε) 294(4.36), 366(4.28) nm; IR (neat) νmax 3380, 2965, 1735, 1661, 1452, 1442, 1381, 1258, 1200, 1152, 852, 802, 758 cm−1; 1H and 13C NMR data; see Table 1. HRESIMS: m/z 511.1975 [M-H] (calcd for C28H31O9, 511.1974).
20-hydroxybislongiquinolide (2): Yellowish amorphous powder; [α]25D + 175 (c = 0.1, MeOH); UV (MeOH) λmax (log ε) 291(4.44), 369(4.36) nm; IR (neat) νmax 3325, 2985, 1741, 1670, 1465, 1453, 1379, 1243, 1202, 1148, 856, 805, 747 cm−1; 1H and 13C NMR data; see Table 1. HRESIMS: m/z 511.1975 [M-H] (calcd for C28H31O9, 511.1974).
14, 20-dihydroxybislongiquinolide (3): Yellowish amorphous powder; [α]25D + 150 (c = 0.1, MeOH); UV (MeOH) λmax (log ε) 287(4.21), 369(4.06) nm; IR (neat) νmax 3451, 2975, 1733, 1656, 1470, 1445, 1383, 1255, 1198, 1146, 870, 802, 751 cm−1; 1H and 13C NMR data; see Table 1. HRESIMS: m/z 527.1925 [M-H] (calcd for C28H31O10, 527.1923).
Acetylchrysopyrone B (5): Yellowish amorphous powder; [α]25D + 174 (c = 0.10, MeOH); UV (MeOH) λmax (log ε) 260(4.12), 355(4.07) nm; IR (neat) νmax 3185, 1735, 1651, 1562, 1423, 1367, 1260, 1145, 1019, 995 cm−1; 1H and 13C NMR data; see Table 2. HRESIMS: m/z 263.0560 [M-H] (calcd for C13H11O6, 263.0561).

3.5. LC-MS/MS and Molecular Networking Analysis

The EtOAc extract of Trichoderma reesei SCNU-F0042 was analyzed by LC−MS/MS. In positive-ionization conditions (m/z 200−800), the mobile phase consisted of 1‰ HCOOH formic acid in H2O and CH3CN. The elution gradient conditions for the LC mobile phase were as follows, based on times (t): t = 0−1 min, hold at 90% H2O/CH3CN; t = 1−10 min, increased linearly to 40% H2O/CH3CN; t = 10−13 min, increased linearly to 10% H2O/CH3CN; t = 13−16 min, hold at 10% H2O/CH3CN; t = 16−16.2 min, increased linearly to 90% H2O/CH3CN; t = 16.2−20 min, hold at 90% H2O/CH3CN with the flow rate of 0.3 mL/min. A total of 1 μL of the sample (c 1 mg/mL, CH3CN) was injected. The MS/MS data of EtOAc extract was first saved as .mzML format files through MSConvert software. The molecular networking was performed using the GNPS data analysis workflow and the spectral clustering algorithm. Parameters for molecular network generation were set as follows: precursor mass tolerance m/z 2.0 Da, fragment ion tolerance m/z 0.5 Da, cosine score above 0.7, minimum matched fragment ions 6, minimum cluster size 2, network TopK10. Data were visualized using Cytoscape 3.8.2 software.

3.6. SARS-CoV-2 Inhibition Assay

3.6.1. Cell Lines and Virus

HEK 293T-hACE2 (ATCC CRL-3216 derived) was described previously [28]. African green monkey kidney epithelial cell line Vero were obtained from The Cell Bank of the Chinese Academy of Sciences, CBCAS, Shanghai, China. HEK 293T-hACE2 and Vero were maintained in Dulbecco’s modified Eagle’s medium (Invitrogen, Carlsbad, CA, USA) containing 10% fetal bovine serum (FBS, GIBCO, Carlsbad, CAe), 2 mM L-glutamine, 100 μg/mL streptomycin and 100 units/mL penicillin (Invitrogen) at 37 °C under 5% CO2. BA.2 (GDPCC 2.00299) was obtained from Guangdong Center for Human Pathogen Culture Collection (GDPCC), Guangdong Provincial Center for Disease Control and Prevention. BA.2 were amplified in Vero cells.

3.6.2. Plasmids

ACE2 packaging construct (GeneCopoeia, EX-U1285-Lv105) uses a cytomegalovirus (CMV) promoter to express ACE2 and bears a puromycin selection marker in the integrating cassette.

3.6.3. RT-qPCR Analysis

HEK 293T-hACE2 cells were seeded in 12-well flat-bottom plate at a density of 1.2 × 104 cells/well. After 24 h, cells were incubated in media consisting of BA.2 (MOI of 0.01) and different concentrations of each compound for 1 h at 37 °C. After the incubation, cells were washed with sterile phosphate-buffered saline (PBS) once and incubated with media mixed with different concentrations of each compound, respectively, for further 48 h. Total RNA of each well was extracted from the cell culture supernatant using LogPure Viral DNA/RNA Kit (Magen, Guangzhou, China). Reverse transcription and qPCR were performed with Detection Kit for Novel Coronavirus (2019-nCoV) RNA (DA0932, DAAN GENE, Guangzhou, China). Samples were read on the QuantStudio7 Flex real-time PCR detection system (Thermo Fisher Scientific, Shanghai, China). The qPCR was performed in duplicates for each sample, and results were calculated using 2–ΔCT, where CT is threshold cycle [29].

3.7. Cell Viability Assay

The test compounds at a serial final concentration of 50 to 1 µM were evaluated against HEK 293T-hACE2 using the MTT method. Tested cell lines were cultured in Dulbecco’s modified Eagle’s medium (DMEM) (Invitrogen, Carlsbad, CA, USA) supplemented with 5% fetal bovine serum (Hyclone, Logan, UT, USA), 2 mM L-glutamine, 100 mg/mL streptomycin, and 100 units/mL penicillin (Invitrogen). The cultures were maintained at 37 °C in a humidified atmosphere of 5% CO2.

4. Conclusions

In summary, three new dimeric sorbicillinoids (13) and one new 3,4,6-trisubstituted α-pyrone (5), together with seven analogues (4 and 611), were isolated from the cultures of the mangrove endophytic fungus Trichoderma reesei SCNU-F0042 under the guidance of MS/MS based on molecular networking. Compound 2 exhibited moderate inhibitory effects on anti-SARS-CoV-2 activity with an EC50 value of 29.0 μM without cytotoxicity observed. Our study enriched the structural and biological activity diversity of sorbicillinoids.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/md21080442/s1, Figure S1: 1H NMR spectrum of compound 1; Figure S2. 13C NMR spectrum of compound 1; Figure S3. 1H, 1H- COSY spectrum of compound 1; Figure S4. HSQC spectrum of compound 1; Figure S5. HMBC spectrum of compound 1; Figure S6. NOESY spectrum of compound 1; Figure S7. HR-ESI-MS spectrum of compound 1; Figure S8. 1H NMR spectrum of compound 2; Figure S9.13C NMR spectrum of compound 2; Figure S10. 1H, 1H-COSY spectrum of compound 2; Figure S11. HSQC spectrum of compound 2; Figure S12. HMBC spectrum of compound 2; Figure S13. NOESY spectrum of compound 2; Figure S14. HR-ESI-MS spectrum of compound 2. Figure S15. 1H NMR spectrum of compound 3; Figure S16.13C NMR spectrum of compound 3; Figure S17. 1H, 1H-COSY spectrum of compound 3; Figure S18. HSQC spectrum of compound 3; Figure S19. HMBC spectrum of compound 3; Figure S20. NOESY spectrum of compound 3; Figure S21. HR-ESI-MS spectrum of compound 3. Figure S22. 1H NMR spectrum of compound 5; Figure S23.13C NMR spectrum of compound 5; Figure S24. 1H, 1H-COSY spectrum of compound 5; Figure S25. HSQC spectrum of compound 5; Figure S26. HMBC spectrum of compound 5; Figure S27. HR-ESI-MS spectrum of compound 5; Figure S28. Molecular networking of the EtOAc extract from strain Trichoderma reesei SCNU-F0042.

Author Contributions

Conceptualization, Y.L.; methodology, J.L. and Y.L.; software, J.L. and T.C.; formal analysis, Y.L.; investigation, J.L., T.C., J.Y., H.J. and C.C.; resources, Y.L.; data curation, Y.L.; writing—original draft preparation, J.L.; writing—review and editing, J.L. and Y.L.; validation, J.L.; visualization, J.L., T.C., J.Y., H.J., C.C. and Y.L.; supervision, Y.L.; project administration, Y.L.; funding acquisition, Y.L. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the Guangdong Marine Economy Development Special Project (No. GDNRC [2023]39 and GDNRC [2022]35) and National Natural Science Foundation of China (No. 41876153).

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Reino, J.L.; Guerrero, R.F.; Hernández-Galán, R.; Collado, I.G. Secondary Metabolites from Species of the Biocontrol Agent Trichoderma. Phytochem. Rev. 2008, 7, 89–123. [Google Scholar] [CrossRef]
  2. Chen, S.; Cai, R.; Liu, Z.; Cui, H.; She, Z. Secondary Metabolites from Mangrove-associated fungi: Source, Chemistry and Bioactivities. Nat. Prod. Rep. 2022, 39, 560–595. [Google Scholar] [CrossRef]
  3. Zhang, L.; Niaz, S.I.; Khan, D.; Wang, Z.; Zhu, Y.; Zhou, H.; Lin, Y.; Li, J.; Liu, L. Induction of Diverse Bioactive Secondary Metabolites from the Mangrove Endophytic Fungus Trichoderma sp. (Strain 307) by Co-Cultivation with Acinetobacter johnsonii (Strain B2). Mar. Drugs 2017, 15, 35. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  4. Zhao, D.-L.; Zhang, X.-F.; Huang, R.-H.; Wang, D.; Wang, X.-Q.; Li, Y.-Q.; Zheng, C.-J.; Zhang, P.; Zhang, C.-S. Antifungal Nafuredin and Epithiodiketopiperazine Derivatives from the Mangrove-Derived Fungus Trichoderma harzianum D13. Front. Microbiol. 2020, 11, 1495. [Google Scholar] [CrossRef]
  5. Zhang, M.; Zhao, J.-L.; Liu, J.-M.; Chen, R.-D.; Xie, K.-B.; Chen, D.-W.; Feng, K.-P.; Zhang, D.; Dai, J.-G. Neural Anti-Inflammatory Sesquiterpenoids from the Endophytic Fungus Trichoderma sp. Xy24. J. Asian Nat. Prod. Res. 2017, 19, 651–658. [Google Scholar] [CrossRef]
  6. Shiono, Y.; Miyazaki, N.; Murayama, T.; Koseki, T.; Harizon; Katja, D.G.; Supratman, U.; Nakata, J.; Kakihara, Y.; Saeki, M.; et al. GSK-3β Inhibitory Activities of Novel Dichroloresorcinol Derivatives from Cosmospora vilior Isolated from a Mangrove Plant. Phytochem. Lett. 2016, 18, 122–127. [Google Scholar] [CrossRef]
  7. Harned, A.M.; Volp, K.A. The Sorbicillinoid Family of Natural Products: Isolation, Biosynthesis, and Synthetic Studies. Nat. Prod. Rep. 2011, 28, 1790–1810. [Google Scholar] [CrossRef] [PubMed]
  8. Cao, Y.; Yang, R.; Zheng, F.; Meng, X.; Zhang, W.; Liu, W. Dual Regulatory Role of Chromatin Remodeler ISW1 in Coordinating Cellulase and Secondary Metabolite Biosynthesis in Trichoderma reesei. Mbio 2022, 13, 03456. [Google Scholar] [CrossRef]
  9. Cram, D.J.; Tishler, M. Mold Metabolites; Isolation of Several Compounds from Clinical Penicillin. J. Am. Chem. Soc. 1948, 70, 4238. [Google Scholar] [CrossRef]
  10. Meng, J.; Wang, X.; Xu, D.; Fu, X.; Zhang, X.; Lai, D.; Zhou, L.; Zhang, G. Sorbicillinoids from Fungi and Their Bioactivities. Molecules 2016, 21, 715. [Google Scholar] [CrossRef] [Green Version]
  11. Rehman, S.; Yang, L.-J.; Zhang, Y.-H.; Wu, J.-S.; Shi, T.; Haider, W.; Shao, C.-L.; Wang, C.-Y. Sorbicillinoid Derivatives from Sponge-Derived Fungus Trichoderma reesei (HN-2016-018). Front. Microbiol. 2020, 11, 1334. [Google Scholar] [CrossRef] [PubMed]
  12. Meng, J.; Wang, B.; Cheng, W. Study on the Secondary Metabolites of Thichoderma sturnisporum. Chin. J. Mar. Drugs 2017, 36, 27–31. [Google Scholar]
  13. Ngo, M.T.; Nguyen, M.V.; Han, J.W.; Park, M.S.; Kim, H.; Choi, G.J. In Vitro and In Vivo Antifungal Activity of Sorbicillinoids Produced by Trichoderma longibrachiatum. J. Fungi 2021, 7, 428. [Google Scholar] [CrossRef] [PubMed]
  14. Zhang, P.; Deng, Y.; Lin, X.; Chen, B.; Li, J.; Liu, H.; Chen, S.; Liu, L. Anti-inflammatory Mono- and Dimeric Sorbicillinoids from the Marine-Derived Fungus Trichoderma reesei 4670. J. Nat. Prod. 2019, 82, 947–957. [Google Scholar] [CrossRef]
  15. Meng, J.; Gu, G.; Dang, P.; Zhang, X.; Wang, W.; Dai, J.; Liu, Y.; Lai, D.; Zhou, L. Sorbicillinoids from the Fungus Ustilaginoidea virens and Their Phytotoxic, Cytotoxic, and Antimicrobial Activities. Front. Chem. 2019, 7, 435. [Google Scholar] [CrossRef] [Green Version]
  16. Pang, X.; Zhou, X.; Lin, X.; Yang, B.; Tian, X.; Wang, J.; Xu, S.; Liu, Y. Structurally Various Sorbicillinoids from the Deep-Sea Sediment Derived Fungus Penicillium sp. SCSIO06871. Bioorg. Chem. 2021, 107, 104600. [Google Scholar] [CrossRef]
  17. Yang, J.Y.; Sanchez, L.M.; Rath, C.M.; Liu, X.; Boudreau, P.D.; Bruns, N.; Glukhov, E.; Wodtke, A.; Felicio, R.; Fenner, A.; et al. Molecular Networking as a Dereplication Strategy. J. Nat. Prod. 2013, 76, 1686–1699. [Google Scholar] [CrossRef] [Green Version]
  18. Andrade, R.; Ayer, W.A.; Trifonov, L.S. The Metabolites of Trichoderma longibrachiatum. III. Two New Tetronic Acids: 5-Hydroxyvertinolide and Bislongiquinolide. Aust. J. Chem. 1997, 50, 255–257. [Google Scholar] [CrossRef]
  19. Yu, J.; Han, H.; Zhang, X.; Ma, C.; Sun, C.; Che, Q.; Gu, Q.; Zhu, T.; Zhang, G.; Li, D. Discovery of Two New Sorbicillinoids by Overexpression of the Global Regulator LaeA in a Marine-Derived Fungus Penicillium dipodomyis YJ-11. Mar. Drugs 2019, 17, 446. [Google Scholar] [CrossRef] [Green Version]
  20. Han, W.; Cai, J.; Zhong, W.; Xu, G.; Wang, F.; Tian, X.; Zhou, X.; Liu, Q.; Liu, Y.; Wang, J. Protein Tyrosine Phosphatase 1B (PTP1B) Inhibitorsfrom the Deep-Sea Fungus Penicillium chrysogenum SCSIO 07007. Bioorg. Chem. 2020, 96, 103646. [Google Scholar] [CrossRef]
  21. Meng, J.; Cheng, W.; Heydari, H.; Wang, B.; Zhu, K.; Konuklugil, B.; Lin, W. Sorbicillinoid-Based Metabolites from a Sponge-Derived Fungus Trichoderma saturnisporum. Mar. Drugs 2018, 16, 226. [Google Scholar] [CrossRef] [Green Version]
  22. Zhao, P.-J.; Li, G.-H.; Shen, Y.-M. New Chemical Constituents from the Endophyte Streptomyces Species LR4612 Cultivated on Maytenus hookeri. Chem. Biodivers. 2006, 3, 337–342. [Google Scholar] [CrossRef] [PubMed]
  23. Andrade, R.; Ayer, W.A.; Trifonov, L.S. The Metabolites of Trichoderma longibrachiatum. Part II The Structures of Trichodermolide and Sorbiquinol. Can. J. Chem. 1996, 74, 371–379. [Google Scholar] [CrossRef] [Green Version]
  24. Abe, N.; Murata, T.; Hirota, A. Novel Oxidized Sorbicillin Dimers with 1,1-Diphenyl-2-Picrylhydrazyl-Radical Scavenging Activity from a Fungus. Biosci. Biotechnol. Biochem. 1998, 62, 2120–2126. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  25. Trifonov, L.S.; Hilpert, H.; Floersheim, P.; Dreiding, A.S.; Rast, D.M.; Skrivanova, R.; Hoesch, L. Bisvertinols: A New Group of Aimeric Vertinoids from Verticillium intertextum. Tetrahedron 1986, 42, 3157. [Google Scholar] [CrossRef]
  26. Kontani, M.; Sakagami, Y.; Marumo, S. First β-1,6-glucan biosynthesis inhibitor, bisvertinolone isolated from fungus, Acremonium strictum and its absolute stereochemistry. Tetrahedron Lett. 1994, 35, 2577. [Google Scholar] [CrossRef]
  27. Liu, J.; Gao, S.; Zhou, W.; Chen, Y.; Wang, Z.; Zeng, Z.; Zhou, H.; Lin, T. Dihydrotrichodimerol Purified from the Marine Fungus Acremonium citrinum Prevents NAFLD by Targeting PPARα. J. Nat. Prod. 2023, 86, 1189–1201. [Google Scholar] [CrossRef]
  28. Oguntuyo, K.Y.; Stevens, C.S.; Hung, C.; Ikegame, S.; Acklin, J.A.; Kowdle, S.S.; Carmichael, J.C.; Chiu, H.P.; Azarm, K.D.; Haas, G.D.; et al. Quantifying Absolute Neutralization Titers against SARS-CoV-2 by a Standardized Virus Neutralization Assay Allows for Cross-Cohort Comparisons of COVID-19 Sera. Mbio 2021, 12, 02492. [Google Scholar] [CrossRef]
  29. Tóth, G.; Horváti, K.; Kraszni, M.; Ausbüttel, T.; Pályi, B.; Kis, Z.; Mucsi, Z.; Kovács, G.M.; Bősze, S.; Boldizsár, I. Arylnaphthalene Lignans with Anti-SARS-CoV-2 and Antiproliferative Activities from the Underground Organs of Linum austriacum and Linum perenne. J. Nat. Prod. 2023, 86, 672–682. [Google Scholar] [CrossRef]
Figure 1. Cluster of nodes from T. reesei with compounds 14.
Figure 1. Cluster of nodes from T. reesei with compounds 14.
Marinedrugs 21 00442 g001
Figure 2. Structure of compounds 111.
Figure 2. Structure of compounds 111.
Marinedrugs 21 00442 g002
Figure 3. 1H, 1H COSY, and key HMBC correlations of compounds 13 and 5.
Figure 3. 1H, 1H COSY, and key HMBC correlations of compounds 13 and 5.
Marinedrugs 21 00442 g003
Figure 4. Key NOESY correlations of compounds 13.
Figure 4. Key NOESY correlations of compounds 13.
Marinedrugs 21 00442 g004
Figure 5. Circular dichroism (CD) spectra of compounds 13.
Figure 5. Circular dichroism (CD) spectra of compounds 13.
Marinedrugs 21 00442 g005
Table 1. 1H and 13C NMR data for compounds 1–3 (methanol-d4).
Table 1. 1H and 13C NMR data for compounds 1–3 (methanol-d4).
NO123
δH (J in Hz)δC, TypeδH (J in Hz)δC, TypeδH (J in Hz)δC, Type
1-63.7, C-63.5, C-63.6, C
2-198.3, C-197.5, C-197.8, C
3-111.7, C-110.2, C-110.5, C
43.34, s43.6, CH3.33, s43.5, CH3.35, s43.6, CH
5-75.9, C-75.8, C-75.8, C
6-210.3, C-210.2, C-210.2, C
73.36, d (5.6)52.2, CH3.31 a52.8, CH3.33 a52.6, CH
83.22, d (5.6)43.9, CH3.28 a43.9, CH3.26 a43.9, CH
9-168.6, C-169.5, C-169.4, C
106.43–6.49 a121.6, CH6.28–6.33119.6, CH6.43–6.46121.5, CH
117.35, dd (14.5, 11.2)142.5, CH7.30, dd (14.7, 11.2)143.7, CH7.37, dd (13.4, 11.5)142.7, CH
126.55–6.59 a129.9, CH6.39–6.43 a132.4, CH6.52–6.60 a129.8, CH
136.25–6.29 a143.0, CH6.19–6.25 a140.6, CH6.26–6.32 a143.3, CH
144.22, d (4.4)63.0, CH21.90, d (6.4)18.9, CH34.23, d (4.1)62.8, CH2
15-203.1, C-202.5, C-202.1, C
166.18, d (15.3)128.8, CH6.30–6.36 a130.0, CH6.31–6.40 a130.1, CH
177.20, dd (15.3, 10.7)147.9, CH7.25, dd (15.4, 10.4)146.8, CH7.27, dd (15.2, 10.3)146.6, CH
186.31–6.35 a131.7, CH6.48–6.53 a128.5, CH6.49–6.52 a128.6, CH
196.38–6.42 a144.9, CH6.45–6.48 a147.6, CH6.48–6.51 a147.5, CH
201.89, d (6.1)19.1, CH34.22, d (4.0)62.7, CH24.23, d (4.1)63.0, CH2
21-84.8, C-84.6, C-84.6, C
22-185.5, C-182.0, C-182.9, C
23-94.7, C-96.2, C-96.1, C
24-179.1, C-178.2, C-178.2, C
1-CH30.99, s11.4, CH30.99, s11.3, CH30.99, s 11.3, CH3
5-CH31.18, s24.1, CH31.18, s24.2, CH31.19, s24.2, CH3
21-CH31.38, s23.3, CH31.40, s23.4, CH31.33, s23.3, CH3
23-CH31.45, s6.4, CH31.48, s6.5, CH31.47, s6.4, CH3
a Overlapped by other signals.
Table 2. 1H and 13C NMR data for compound 5 (acetone-d6).
Table 2. 1H and 13C NMR data for compound 5 (acetone-d6).
NOδH (J in Hz)δC, Type
2-163.6, C
3-115.5, C
4-158.9, C
56.47, s106.6, CH
6-155.6, C
7-167.9, C
82.34, s20.8, CH3
1′6.70, d (15.2)130.2, CH
2′7.15, dd (15.2, 11.5)132.2, CH
3′7.37, dd (15.2, 11.5)143.4, CH
4′6.28, d (15.2)126.6, CH
5′-167.4, C
3-CH31.91, s10.3, CH3
Table 3. Results of anti-SARS-CoV-2 activity and cytotoxicity for 293T cell.
Table 3. Results of anti-SARS-CoV-2 activity and cytotoxicity for 293T cell.
CompoundInhibition of SARS-CoV-2 Viruses (EC50/μM) bCytotoxicity for 293T Cell (IC50/μM) b
1NS c>80
229.0>80
3NS>80
5NS>80
Remdesivir a1.2>80
a Positive control; b Data are shown as mean from three parallel experiments; c NS means not sensitive at 80 μM.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Li, J.; Chen, T.; Yu, J.; Jia, H.; Chen, C.; Long, Y. New Sorbicillinoids from the Mangrove Endophytic Fungus Trichoderma reesei SCNU-F0042. Mar. Drugs 2023, 21, 442. https://doi.org/10.3390/md21080442

AMA Style

Li J, Chen T, Yu J, Jia H, Chen C, Long Y. New Sorbicillinoids from the Mangrove Endophytic Fungus Trichoderma reesei SCNU-F0042. Marine Drugs. 2023; 21(8):442. https://doi.org/10.3390/md21080442

Chicago/Turabian Style

Li, Jialin, Tao Chen, Jianchen Yu, Hao Jia, Chen Chen, and Yuhua Long. 2023. "New Sorbicillinoids from the Mangrove Endophytic Fungus Trichoderma reesei SCNU-F0042" Marine Drugs 21, no. 8: 442. https://doi.org/10.3390/md21080442

APA Style

Li, J., Chen, T., Yu, J., Jia, H., Chen, C., & Long, Y. (2023). New Sorbicillinoids from the Mangrove Endophytic Fungus Trichoderma reesei SCNU-F0042. Marine Drugs, 21(8), 442. https://doi.org/10.3390/md21080442

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop